Literature DB >> 19114029

Investigating the role of class-IA PI 3-kinase isoforms in adipocyte differentiation.

Ji Eun Kim1, Peter R Shepherd, Claire Chaussade.   

Abstract

PI 3-kinases, in particular class-IA, are key signalling molecules controlling many cellular processes including growth, proliferation, migration and differentiation. In this study, we have used a collection of isoform selective PI 3-kinase inhibitors to determine whether attenuation of signalling through class-IA PI 3-kinase isoforms will impact adipocyte differentiation. First, we analysed the expression profiles and found that fibroblastic pre-adipocytes express detectable levels of p110alpha and p110delta and that after differentiation, p110delta levels fall while p110alpha levels rise, together with C/EBPalpha and PPARgamma. When using specific inhibitors during the differentiation process, we observed that neither p110beta nor p110delta inhibition, had any significant effect. In contrast PIK-75, a selective p110alpha inhibitor completely abolished adipocyte differentiation as assessed by morphology, transcript and protein levels of adipocyte markers. These results indicate that long term treatment with p110alpha inhibitors could potentially have a severe impact on fat cell numbers in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19114029     DOI: 10.1016/j.bbrc.2008.12.089

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Ablation of PI3K-p110alpha Impairs Maternal Metabolic Adaptations to Pregnancy.

Authors:  Jorge Lopez-Tello; Esteban Salazar-Petres; Liam Webb; Abigail L Fowden; Amanda N Sferruzzi-Perri
Journal:  Front Cell Dev Biol       Date:  2022-07-01

2.  Comparison of growth factor signalling pathway utilisation in cultured normal melanocytes and melanoma cell lines.

Authors:  Ji Eun Kim; Clare Stones; Wayne R Joseph; Euphemia Leung; Graeme J Finlay; Andrew N Shelling; Wayne A Phillips; Peter R Shepherd; Bruce C Baguley
Journal:  BMC Cancer       Date:  2012-04-04       Impact factor: 4.430

3.  Effects of acutely inhibiting PI3K isoforms and mTOR on regulation of glucose metabolism in vivo.

Authors:  Greg C Smith; Wee Kiat Ong; Gordon W Rewcastle; Jackie D Kendall; Weiping Han; Peter R Shepherd
Journal:  Biochem J       Date:  2012-02-15       Impact factor: 3.857

Review 4.  For Better or Worse: The Potential for Dose Limiting the On-Target Toxicity of PI 3-Kinase Inhibitors.

Authors:  Christina M Buchanan; Kate L Lee; Peter R Shepherd
Journal:  Biomolecules       Date:  2019-08-22

5.  Heterogeneity of expression of epithelial-mesenchymal transition markers in melanocytes and melanoma cell lines.

Authors:  Ji Eun Kim; Euphemia Leung; Bruce C Baguley; Graeme J Finlay
Journal:  Front Genet       Date:  2013-05-31       Impact factor: 4.599

6.  Protein kinase activity of phosphoinositide 3-kinase regulates cytokine-dependent cell survival.

Authors:  Daniel Thomas; Jason A Powell; Benjamin D Green; Emma F Barry; Yuefang Ma; Joanna Woodcock; Stephen Fitter; Andrew C W Zannettino; Stuart M Pitson; Timothy P Hughes; Angel F Lopez; Peter R Shepherd; Andrew H Wei; Paul G Ekert; Mark A Guthridge
Journal:  PLoS Biol       Date:  2013-03-19       Impact factor: 8.029

7.  Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism.

Authors:  Lazaros C Foukas; Benoit Bilanges; Lucia Bettedi; Wayne Pearce; Khaled Ali; Sara Sancho; Dominic J Withers; Bart Vanhaesebroeck
Journal:  EMBO Mol Med       Date:  2013-03-11       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.